you are here: Home News Gsk

Gsk

Pharma major GSK's CEO to step down after a nine-year term in surprise announcement amid Trump tariffs
GSK’s profit outshines estimates as vaccines keep growing
Pfizer wins bid to invalidate GSK's patents over RSV vaccine
GSK plans to buy Canada's Bellus Health for $2 billion to expand on respiratory therapies
Unilever CEO Alan Jope to retire at end of 2023 after GSK setback
GSK’s got heartburn that £50 billion could probably fix
Telangana drug sleuths to crack down on large counterfeit drug cartels
Sanofi, GSK Covid-19 vaccine found effective against Omicron
Pfizer to exit GSK's consumer health arm after spin-off
Unilever | Could the hunter become the hunted?
Lex | GSK: £50bn-plus takeover would leave Unilever omnileveraged
New data shows GSK-Vir drug works against all Omicron mutations
Sanofi, GSK get approval to conduct phase 3 trial of COVID-19 vaccine in India
COVID-19 vaccine | Sanofi to seek permission for Phase 3 trial in India: Report
COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study
Meet Sudhir Sitapati, Godrej consumer’s new top boss
Glenmark Pharma’s Kaizad Hazari to become General Counsel of Arcelor Mittal Nippon Steel India; Ex- Dr Reddy’s Suprio Dasgupta to replace Hazari
GSK, Sanofi begin new COVID-19 vaccine trial after setback last year
GSK, CureVac partnership eyes COVID-19 vaccine against multiple variants
GSK, Sanofi to make 200 million doses available for COVID-19 vaccine alliance
GlaxoSmithKline to launch late-stage testing of syncytial virus vaccine
Sanofi and GSK launch trial for COVID-19 protein-based vaccine
Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK
Britain's GSK to take 10% stake in Germany's CureVac for $163 million
COVID-19 vaccine | Britain nears 500 million pound deal with GSK, Sanofi: Report

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Gsk

Pharma major GSK's CEO to step down after a nine-year term in surprise announcement amid Trump tariffs

GSK’s profit outshines estimates as vaccines keep growing

Pfizer wins bid to invalidate GSK's patents over RSV vaccine

GSK plans to buy Canada's Bellus Health for $2 billion to expand on respiratory therapies

Unilever CEO Alan Jope to retire at end of 2023 after GSK setback

GSK’s got heartburn that £50 billion could probably fix

Telangana drug sleuths to crack down on large counterfeit drug cartels

Sanofi, GSK Covid-19 vaccine found effective against Omicron

Pfizer to exit GSK's consumer health arm after spin-off

Unilever | Could the hunter become the hunted?

Lex | GSK: £50bn-plus takeover would leave Unilever omnileveraged

New data shows GSK-Vir drug works against all Omicron mutations

Sanofi, GSK get approval to conduct phase 3 trial of COVID-19 vaccine in India

COVID-19 vaccine | Sanofi to seek permission for Phase 3 trial in India: Report

COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study

Meet Sudhir Sitapati, Godrej consumer’s new top boss

Glenmark Pharma’s Kaizad Hazari to become General Counsel of Arcelor Mittal Nippon Steel India; Ex- Dr Reddy’s Suprio Dasgupta to replace Hazari

GSK, Sanofi begin new COVID-19 vaccine trial after setback last year

GSK, CureVac partnership eyes COVID-19 vaccine against multiple variants

GSK, Sanofi to make 200 million doses available for COVID-19 vaccine alliance

GlaxoSmithKline to launch late-stage testing of syncytial virus vaccine

Sanofi and GSK launch trial for COVID-19 protein-based vaccine

Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK

Britain's GSK to take 10% stake in Germany's CureVac for $163 million

COVID-19 vaccine | Britain nears 500 million pound deal with GSK, Sanofi: Report